Back to Market Feed

XIIDRA 5% EYE DROPS

$11.8386per EA

Strength

50 mg/mL

Manufacturer

Novartis Pharmaceuticals Corporation

NDC

00078091112

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

1/1/2026

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

7/11/2016

Pharmacological Classes

Lymphocyte Function-Associated Antigen-1 Antagonist

Lymphocyte Function-Associated Antigen-1 Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.8%

3Y

+8.1%

5Y

+25.1%

All

+33.6%

Generic Alternatives

1 alternative • Same active ingredient

XIIDRA 5% EYE DROPS

24208091112•Bausch & Lomb Incorporated

Related Drugs

Same classification

No related drugs found.